Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000515010 | SCV000610411 | pathogenic | not provided | 2017-06-14 | criteria provided, single submitter | clinical testing | |
Knight Diagnostic Laboratories, |
RCV001270130 | SCV001449000 | likely pathogenic | Primary ciliary dyskinesia 28 | 2018-06-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000515010 | SCV001776547 | pathogenic | not provided | 2024-02-23 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 30293640) |
Fulgent Genetics, |
RCV001270130 | SCV002779743 | likely pathogenic | Primary ciliary dyskinesia 28 | 2022-04-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001270130 | SCV003440549 | pathogenic | Primary ciliary dyskinesia 28 | 2023-04-01 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 445743). This premature translational stop signal has been observed in individual(s) with primary ciliary dyskinesia (PMID: 24055112). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs751845138, gnomAD 0.005%). This sequence change creates a premature translational stop signal (p.Lys301Thrfs*4) in the SPAG1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPAG1 are known to be pathogenic (PMID: 24055112). |